MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Benefit of Telemedicine Usage in Parkinson’s Disease Patients in Appalachia

    S. Rashid, D. Fletcher, J. Frey (Morgantown, USA)

    Objective: To assess telehealth patterns on socioeconomic and geographic factors and time to surgery in  patients with Parkinson’s Disease (PD) evaluated for deep brain stimulation…
  • 2026 International Congress

    The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

    R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)

    Objective: This study aims to evaluate the clinical, humanistic, and societal impact of delayed SC therapy in patients with PD. Background: As Parkinson’s disease (PD)…
  • 2026 International Congress

    Bidirectional associations between seizures and parkinsonism: a retrospective case series

    Y. Chen, J. Fleisher, R. O'Dwyer (Chicago, USA)

    Objective: Within a single center, describe individuals with parkinsonism who develop seizures and vice versa based on epilepsy and movement disorders evaluation. Background: While neurodegeneration…
  • 2026 International Congress

    A Novel Clinical Protocol for Monitoring Therapeutic Outcomes in Camptocormia in Parkinson´s Disease

    L. Lundh, E. Franzén, S. Grigoriou, M. Söderholm, W. Duzynski, F. Strömqvist, B. Lindholm (Ängelholm, Sweden)

    Objective: To present a case study using a novel protocol evaluating postural, pain, and respiratory outcome in PD-related camptocormia before and after treatment. Background: Camptocormia…
  • 2026 International Congress

    Qihuang Needle Therapy for Motor Symptoms in Parkinson’s Disease: A Randomized Controlled Trial

    WQ. Peng, RH. Zhao, ZT. Huang, NB. Wang, ZH. Chen (Guangzhou, China)

    Objective: To evaluate the efficacy of Qihuang needle therapy for improving motor and non-motor symptoms in patients with Parkinson’s disease (PD). Background: Motor symptoms in…
  • 2026 International Congress

    Survival and Related Factors in Patients with Parkinson’s Disease : A Multicenter Prospective Cohort Study in China

    S. Song, L. Xiang, Y. Liu, H. Pan, Y. Wu, X. Li, F. Luo, C. Wang, L. Lei, L. Yao, Y. Zhao, Z. Liu, Q. Sun, J. Guo, B. Tang, I. Wu, L. Yin, X. Zhou, Q. Xu (Changsha, China)

    Objective: To estimate mortality, standardized mortality ratios (SMRs), causes of death, and survival-related risk factors in a large, multicenter Parkinson’s disease (PD) cohort from the…
  • 2026 International Congress

    In Vivo 18F-Florzolotau Tau PET Imaging in Parkinson’s Disease with and without Probable REM Sleep Behavior Disorder

    C. Xu, Y. Tang, J. Wang (Shanghai, China)

    Objective: To investigate the distribution and potential influence of tau pathology in Parkinson’s disease (PD) patients with and without prodromal REM sleep behavior disorder (pRBD),…
  • 2026 International Congress

    Changes in Continuous Good ON and Best ON Time During the Waking Day With Tavapadon in People With Parkinson’s Disease

    R. Hauser, R. Dhall, D. Kremens, L. Harmer, K. Chan, J. Ma (Tampa, USA)

    Objective: To evaluate motor states throughout the waking day when tavapadon is added to oral carbidopa/levodopa in adults with Parkinson’s disease (PD) experiencing motor fluctuations.…
  • 2026 International Congress

    Early Clinical Characteristics of Pathologically Confirmed Progressive Supranuclear Palsy and Corticobasal Degeneration

    SKS. Ting, S. Asahara Thio, K. Cao, S. Hameed, WS. Li, J. Mukesh Shah, S. Lin, JW. Sim, HJ. Chiew, KP. Ng, ASL. Ng (Singapore, Singapore)

    Objective: This study aimed to characterize the early clinical features of PSP and CBD to inform clinicians on diagnostic assessment and management strategies. Background: Although…
  • 2026 International Congress

    Comparative efficacy and safety of Safinamide versus Opicapone in Japanese patients with Parkinson’s Disease and wearing-off: A matching-adjusted indirect comparison

    N. Nishikawa, R. Ando, T. Ishida, T. Hatano, N. Hattori, M. Nomoto (Tokyo, Japan)

    Objective: To compare efficacy and safety outcomes with safinamide and opicapone as adjuncts to levodopa in Parkinson’s disease (PD) patients with wearing-off using an anchored…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley